CAN since the time of its discovery has been implicated as an anticancer molecule for its ability to inhibit PP2A, DNA repair proteins, cancer metastasis, etc. Though few genetic targets of this molecule are very well established, other potential genetic targets remain unexplored. The gene discussed is XRCC6P5; the disease is cancer.